Robert Sexton

Head, Commercial Strategy, Insights, & Analytics at Legend Biotech

Speaker

Robert Sexton is an accomplished biopharma executive with over 20 years of experience driving strategic leadership, commercialization, market access, and patient support within the oncology and hematology sectors. He has played a pivotal role in launching first-in-class therapies, including transformative cell and gene therapies such as Kymriah and Carvykti, achieving significant market adoption and improving patient access. His expertise extends to building integrated strategies that bridge clinical innovation with operational excellence, ensuring that life-changing treatments reach patients efficiently and effectively. With a focus on advancing care in complex therapeutic areas, Robert has successfully led cross-functional teams to deliver impactful results in highly competitive markets.

A cancer survivor, Robert brings a deeply personal perspective to his work in the healthcare industry, driven by a commitment to advancing innovative therapies that improve patient outcomes. As a thought leader and innovator, he has pioneered groundbreaking approaches, from developing outcome-based agreements to designing proprietary digital ecosystems that enhance the patient and provider experience.

Robert’s academic foundation includes a Master of Science in Biotechnology from Johns Hopkins University, an MBA in Strategic Marketing from Monmouth University, and executive education from the Wharton School. These credentials, combined with his journey as both a patient and a leader, reflect his unwavering dedication to leveraging science and strategic innovation to transform lives.

Robert lives in Holmdel, NJ, with his wife and their five children. His family serves as a source of inspiration, reinforcing his commitment to advancing healthcare solutions that transform lives and create a brighter future for patients worldwide.